---
title: "PAGAN DOUGLAS W. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ef5902df-8272-5085-aaa2-5b686c8ea34b
json: https://whiteintel.dev/api/public/dossier/ef5902df-8272-5085-aaa2-5b686c8ea34b
identifier: sec:0001628880
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# PAGAN DOUGLAS W.

**Type:** Company  
**Jurisdiction:** US  
**Identifier:** `sec:0001628880`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/ef5902df-8272-5085-aaa2-5b686c8ea34b  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ef5902df-8272-5085-aaa2-5b686c8ea34b  

## Ownership & control

### Holdings / subsidiaries

- **KAILERA THERAPEUTICS, INC.** (officer) — https://whiteintel.dev/entity/a374bc29-832b-57f1-ae15-b2c2c939a417
- **DICERNA PHARMACEUTICALS INC** (officer) — https://whiteintel.dev/entity/e266421a-23a3-55f8-9ed4-831e91084e35
- **Alaunos Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/acf1f452-e0aa-5e8b-ba88-a451176ca5cb
- **NOVACEA INC** (officer) — https://whiteintel.dev/entity/ae254050-c680-5a04-8774-2e41a4af64eb

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **PAGAN DOUGLAS W.**. Human view: https://whiteintel.dev/entity/ef5902df-8272-5085-aaa2-5b686c8ea34b · Structured JSON: https://whiteintel.dev/api/public/dossier/ef5902df-8272-5085-aaa2-5b686c8ea34b._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._